title: Vitrification of oocytes, embryos and blastocysts.
abstract: In assisted reproductive technology, cryopreservation of human oocytes and embryos has been significantly improved by refined slow-cooling and the new vitrification method. The slow-cooling method requires a programmed cryo-machine, and usually takes several hours. It is, however, difficult to eliminate injuries resulting from ice formation completely. Vitrification has become a reliable strategy because it is simple, can lead to high survival rates and viability, and has better clinical outcome. Vitrification transforms cells into an amorphous glassy state inside and outside the vitrified cell with ultra-rapid cooling and warming steps by plunging the oocytes and embryos into liquid nitrogen, instead of ice-crystal formation. Over the past decade, several advances in vitrification technologies have improved clinical efficiency and outcome. In this chapter, we focus on vitrification technologies for cryopreservation in human assisted reproductive technology.
authors.affiliation: Hiroshima HART Clinic, 5-7-10 Ohtemchi, Naka-ku, Hiroshima 730-0051, Japan. info@hiroshima-hart.jp
authors.forename: Tetsunori
authors.initials: T
authors.lastname: Mukaida
authors.forename: Chikahiro
authors.initials: C
authors.lastname: Oka
mesh_terms: D001755:Blastocyst; D015925:Cryopreservation / Q000295:instrumentation / Q000379:methods*; D004624:Embryo Transfer; D004622:Embryo, Mammalian; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006801:Humans; D007246:Infertility / Q000628:therapy; D009865:Oocytes; D016896:Treatment Outcome; D058989:Vitrification